3C-like protease
In silico Repositioning for Dual Inhibitor Discovery of SARS-CoV-2 (COVID- 19) 3C-like Protease and Papain-like Peptidase
41
3C-like protease of rabbit hemorrhagic disease virus: identification of cleavage sites in the ORF1 polyprotein and analysis of cleavage specificity.
10
Polyprotein processing in Southampton virus: identification of 3C-like protease cleavage sites by in vitro mutagenesis.
6
Identification of Active-Site Amino Acid Residues in the Chiba Virus 3C-Like Protease
10
Genetic Screen for Monitoring Severe Acute Respiratory Syndrome Coronavirus 3C-Like Protease
5
Coronaviruses Resistant to a 3C-Like Protease Inhibitor Are Attenuated for Replication and Pathogenesis, Revealing a Low Genetic Barrier but High Fitness Cost of Resistance
13
Porcine Epidemic Diarrhea Virus 3C-Like Protease Regulates Its Interferon Antagonism by Cleaving NEMO
12
Characterization of an Alphamesonivirus 3C-Like Protease Defines a Special Group of Nidovirus Main Proteases
12
Porcine Epidemic Diarrhea Virus 3C-Like Protease-Mediated Nucleocapsid Processing: Possible Link to Viral Cell Culture Adaptability
13
Mouse Hepatitis Virus 3C-Like Protease Cleaves a 22-Kilodalton Protein from the Open Reading Frame 1a Polyprotein in Virus-Infected Cells and In Vitro
7
Mechanism for Controlling the Dimer-Monomer Switch and Coupling Dimerization to Catalysis of the Severe Acute Respiratory Syndrome Coronavirus 3C-Like Protease
10
Identification and characterization of a 3C-like protease from rabbit hemorrhagic disease virus, a calicivirus.
9
Molecular Characterization of a Porcine Enteric Calicivirus Genetically Related to Sapporo-Like Human Caliciviruses
7
Highly Conserved Configuration of Catalytic Amino Acid Residues among Calicivirus-Encoded Proteases
9
Efficient Cleavage of Ribosome-Associated Poly(A)-Binding Protein by Enterovirus 3C Protease
13
Serological Evidence of Human Klassevirus Infection
5
Chlamydial Protease Like Activity Factor and Type III Secreted Effectors Cooperate in Inhibition of p65 Nuclear Translocation
9
Virtual screening and molecular docking of Anti-Antileishmanial for selected pharmacophore for visceral Leishmaniasis
6
Identification of active-site residues in protease 3C of hepatitis A virus by site-directed mutagenesis.
7
Structural Basis for Antiviral Inhibition of the Main Protease, 3C, from Human Enterovirus 93
10